跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 106,231 条关于
“recurrent cervical cancer”
全部
106,231
临床试验
87,568
药物
2,246
机构
1,103
资讯
15,314
去年
Cadonilimab Plus Chemotherapy and Bevacizumab Improves Outcomes in Recurrent Cervical Cancer
6个月前
Cbio Receives European Clearance for First-in-Human Trial of Novel T-Cell Therapy in Cervical Cancer
去年
EU Committee Recommends Approval of Pfizer and Genmab's Tivdak for Cervical Cancer
9个月前
UK Approves Tisotumab Vedotin for Recurrent Cervical Cancer, Demonstrating 30% Reduction in Death Risk
去年
Iparomlimab/Tuvonralimab Plus Chemotherapy Shows Promise in Recurrent/Metastatic Cervical Cancer
2年前
Iparomlimab/Tuvonralimab Plus Chemo Shows Promise in Recurrent/Metastatic Cervical Cancer
6个月前
NICE Reverses Decision, Approves Genmab's Tivdak for NHS Use in Cervical Cancer
去年
Cadonilimab Plus Chemotherapy Improves Survival in Cervical Cancer
去年
Neratinib (NERLYNX®) Included in NCCN Guidelines for HER2-Mutated Cervical Cancer
5年前
Libtayo (Cemiplimab) Monotherapy Demonstrates Overall Survival Benefit in Advanced Cervical Cancer
第 1 页，共 1532 页
上一页
下一页
